SHR-1701

SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer

Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma.

Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

SHR-1701 Combined with SHR2554 and BP102 for MCRC

A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer

Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC

A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

A Trial of SHR-1701 in Subjects With Advanced Solid Tumors

SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors

Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer